Metropolitan Life Insurance Company (MetLife)’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,108
Closed -$41.2K 667
2024
Q1
$41.2K Sell
3,108
-367
-11% -$5.68K ﹤0.01% 1504
2023
Q4
$65.8K Hold
3,475
﹤0.01% 1302
2023
Q3
$52.3K Buy
3,475
+331
+11% +$6.21K ﹤0.01% 1374
2023
Q2
$67.9K Hold
3,144
﹤0.01% 1243
2023
Q1
$88.4K Sell
3,144
-489
-13% -$13.9K ﹤0.01% 1054
2022
Q4
$91.9K Buy
3,633
+100
+3% +$3.06K ﹤0.01% 1097
2022
Q3
$102K Hold
3,533
﹤0.01% 1008
2022
Q2
$89.5K Buy
+3,533
New +$102K ﹤0.01% 1118

Other funds holding EMBC

Metropolitan Life Insurance Company (MetLife)'s EMBC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Embecta (EMBC) in Q2 2024, closing a stake of 3,108 shares — an estimated $41.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EMBC in Q2 2022 and held it in 8 quarters. The position peaked at $102K in Q3 2022. 361 funds tracked by Wall St. Rank hold EMBC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Embecta position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,108 Embecta shares in Q2 2024, an estimated $41.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Embecta in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Embecta position peaked at $102K in Q3 2022.
  • 361 funds tracked by Wall St. Rank held Embecta as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.